Amiksin tab. p / o captivity.

Structure

Active substance:

Tilorone 60 mg in 1 tablet.

Excipients: basic magnesium carbonate, polyvinylpyrrolidone, calcium stearate, aerosil, vaseline oil, sugar, talc, tropeolin O, titanium dioxide, gelatin, beeswax.

pharmachologic effect

Pharmaceutical group:

antiviral immunostimulating agent - an inducer of interferon formation.

Pharmaceutical action:

Amiksin is a low-molecular-weight synthetic interferon inducer that stimulates the formation of alpha, beta and gamma interferons in the body.

The main producers of interferon in response to the administration of tilorone are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes.

After oral administration, the maximum production of interferon is determined in the sequence intestines - liver - blood after 4-24 hours.

Amiksin has an immunomodulatory and antiviral effect.

In human leukocytes, it induces the synthesis of interferon.

Stimulates bone marrow stem cells, depending on the dose, increases antibody production, reduces the degree of immunosuppression, restores the ratio of T-suppressors and T-helpers.

Effective against various viral infections, including influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpes viruses.

The mechanism of antiviral action is associated with inhibition of the translation of virus-specific proteins in infected cells, as a result of which the reproduction of viruses is suppressed.

Pharmacokinetics:

After oral administration, it is rapidly absorbed from the gastrointestinal tract.

Bioavailability - 60%.

About 80% of the drug binds to plasma proteins.

The drug is excreted practically unchanged through the intestines (70%) and through the kidneys (9%).

The half-life (T1 / 2) is 48 hours. The drug does not undergo biotransformation and does not accumulate in the body.

Indications

In adults:

For the treatment of viral hepatitis A, B and C.

For the treatment of herpes infection.

For the treatment of cytomegalovirus infection.

As part of the complex therapy of allergic and viral encephalomyelitis (including multiple sclerosis, leukoencephalitis, uveoencephalitis).

As part of the complex therapy of urogenital and respiratory chlamydia.

As part of the complex therapy of pulmonary tuberculosis.

For the prevention and treatment of influenza and ARVI.

In children over 7 years old

For the treatment of influenza and SARS.

Application during pregnancy and lactation

Amiksin is contraindicated for use during pregnancy and lactation.

Contraindications

Children under 7 years old.

Pregnancy.

Lactation period (breastfeeding).

Hypersensitivity to the drug.

Side effects

From the digestive system:

Symptoms of dyspepsia are possible.

Others:

Short-term chills are possible.

Allergic reactions.

Interaction

Amiksin is compatible with antibiotics and traditional treatments for viral and bacterial infections.

How to take, course of administration and dosage

The drug is taken orally after meals.

Prescribing to children over 7 years of age with uncomplicated forms of influenza and other acute respiratory viral infections

For children over 7 years of age with uncomplicated forms of influenza or other acute respiratory viral infections, the drug is prescribed at a dose of 60 mg (1 tab.) 1 time / day after meals on the 1st, 2nd and 4th days from the start of treatment.

Heading dose - 0.18 g (3 tab.).

Development of complications of influenza and other acute respiratory viral infections.

With the development of complications of influenza and other acute respiratory viral infections, the drug is taken at 60 mg 1 time / day on the 1st, 2nd, 4th, 6th day from the start of treatment.

Heading dose - 0.24 g (4 tab.).

Overdose

To date, cases of overdose of the drug Amiksin are unknown.

Release form

Film-coated tablets.

Storage conditions

In a dry, dark place at a temperature not exceeding 30 В° C

Shelf life

3 years

Active substance

Tiloron

Name ENG

AMIXIN

Clinical and pharmacological group

Antiviral and immunomodulatory drug.

Interferon synthesis inductor

ATX code

Other antiviral drugs

Dosage

60mg

Structure

Active ingredient: Tiloron 60 mg in 1 tablet. Excipients: basic magnesium carbonate, polyvinylpyrrolidone, calcium stearate, aerosil, vaseline oil, sugar, talc, tropeolin O, titanium dioxide, gelatin, beeswax.

Indications

In adults: For the treatment of viral hepatitis A, B and C. For the treatment of herpes infection.

For the treatment of cytomegalovirus infection.

As part of the complex therapy of allergic and viral encephalomyelitis (including multiple sclerosis, leukoencephalitis, uveoencephalitis).

As part of the complex therapy of urogenital and respiratory chlamydia.

As part of the complex therapy of pulmonary tuberculosis.

For the prevention and treatment of influenza and ARVI.

In children over 7 years of age For the treatment of influenza and ARVI.

Storage conditions and periods

At a temperature not exceeding 30 degrees (in original packaging).

Expiration date: 3 years

Contraindications

Pregnancy.

Lactation period (breastfeeding).

Children under 7 years old.

Hypersensitivity to the drug.

INN / Active ingredient

Tiloron

Specifications

Category

Antiviral

,

Antimicrobial agents

Scope of the drug

The immune system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

ten

Vacation conditions

Without recipe

Brand name

OTCPharm

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

J05AX Other antiviral drugs

Dosage form

Film-coated tablets

Dosage (volume) of the substance in the preparation

tilorone (tilaxin) 60 mg

Expiration date in days

1095

The target audience

Children

Package weight, g

ten

Mode of application

:

The drug is taken orally after a meal. < br> Prescription for children over 7 years of age with uncomplicated forms of influenza and other acute respiratory viral infections < br> Children over 7 years of age with uncomplicated forms of influenza or other acute respiratory viral infections are prescribed the drug at a dose of 60 mg (1 tab.) 1 time / day after eating on the 1st, 2nd and 4th day from the start of treatment.

Heading dose - 0.18 g (3 tab.).

< br> Development of complications of influenza and other acute respiratory viral infections. < br> With the development of complications of influenza and other acute respiratory viral infections, the drug is taken at 60 mg 1 time / day on the 1st, 2nd, 4th, 6th days from the start of treatment.

Heading dose - 0.24 g (4 tab.).

Pharmaco-therapeutic group

:

Antiviral immunostimulating agent - inducer of interferon formation

Information on technical characteristics, delivery set, country of manufacture